Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Vincerx Pharma, Inc. (LSAC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Seelenberger Alexander A. (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Bought 10,500 shares
@ $0.9493, valued at
$10k
|
|
| 08/10/2023 |
4
| Hamdy Ahmed MD (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Bought 16,900 shares
@ $0.9464, valued at
$16k
Bought 5,400 shares
@ $0.9569, valued at
$5.2k
|
|
| 08/10/2023 |
4
| THOMAS TOM C (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Bought 5,000 shares
@ $0.95, valued at
$4.8k
|
|
| 08/10/2023 |
4
| Izumi Raquel E. (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Bought 13,036 shares
@ $0.9002, valued at
$11.7k
Bought 3,440 shares
@ $0.93, valued at
$3.2k
|
|
| 08/07/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2023 |
SC 13G
| Long Focus Capital Management, LLC reports a 6.7% stake in Vincerx Pharma, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| GOLDMAN SACHS GROUP INC reports a 10.1% stake in VINCERX PHARMA, INC. |
| 02/08/2023 |
SC 13G
| GOLDMAN SACHS GROUP INC reports a 9.8% stake in VINCERX PHARMA, INC. |
| 01/03/2023 |
8-K
| Quarterly results |
| 12/29/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/31/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/29/2022 |
4
| Seelenberger Alexander A. (CFO) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Granted 58,000 options to buy
@ $1.71, valued at
$99.2k
|
|
| 08/29/2022 |
4
| Hamdy Ahmed MD (CEO) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Granted 60,000 options to buy
@ $1.71, valued at
$102.6k
|
|
| 08/29/2022 |
4
| Izumi Raquel E. (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Granted 60,000 options to buy
@ $1.71, valued at
$102.6k
|
|
| 08/29/2022 |
4
| THOMAS TOM C (See Remarks) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Granted 58,000 options to buy
@ $1.71, valued at
$99.2k
|
|
| 08/26/2022 |
4
| LOWE CHRISTOPHER P. (Director) has filed a Form 4 on Vincerx Pharma, Inc.|
Txns:
| Bought 18,400 shares
@ $1.6467, valued at
$30.3k
Bought 11,600 shares
@ $1.6499, valued at
$19.1k
|
|
|
|
|